Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385986146> ?p ?o ?g. }
- W4385986146 endingPage "2071" @default.
- W4385986146 startingPage "2059" @default.
- W4385986146 abstract "BACKGROUND: Type 1 diabetes (T1D) is a major cause of endothelial dysfunction. Although cellular bioenergetics has been identified as a new regulator of vascular function, whether glycolysis, the primary bioenergetic pathway in endothelial cells (EC), regulates vascular tone and contributes to impaired endothelium-dependent relaxation (EDR) in T1D remains unknown. METHODS: Experiments were conducted in Akita mice with intact or selective deficiency in EC PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3), the main regulator of glycolysis. Seahorse analyzer and myography were employed to measure glycolysis and mitochondrial respiration, and EDR, respectively, in aortic explants. EC PFKFB3 (Ad-PFKFB3) and glycolysis (Ad-GlycoHi) were increased in situ via adenoviral transduction. RESULTS: T1D increased EC glycolysis and elevated EC expression of PFKFB3 and NADPH oxidase Nox1 (NADPH oxidase homolog 1). Functionally, pharmacological and genetic inhibition of PFKFB3 restored EDR in T1D, while in situ aorta EC transduction with Ad-PFKFB3 or Ad-GlycoHi reproduced the impaired EDR associated with T1D. Nox1 inhibition restored EDR in aortic rings from Akita mice, as well as in Ad-PFKFB3-transduced aorta EC and lactate-treated wild-type aortas. T1D increased the expression of the advanced glycation end product precursor methylglyoxal in the aortas. Exposure of the aortas to methylglyoxal impaired EDR, which was prevented by PFKFB3 inhibition. T1D and exposure to methylglyoxal increased EC expression of HIF1α (hypoxia-inducible factor 1α), whose inhibition blunted methylglyoxal-mediated EC PFKFB3 upregulation. CONCLUSIONS: EC bioenergetics, namely glycolysis, is a new regulator of vasomotion and excess glycolysis, a novel mechanism of endothelial dysfunction in T1D. We introduce excess methylglyoxal, HIF1α, and PFKFB3 as major effectors in T1D-mediated increased EC glycolysis." @default.
- W4385986146 created "2023-08-19" @default.
- W4385986146 creator A5015104391 @default.
- W4385986146 creator A5016702603 @default.
- W4385986146 creator A5016817055 @default.
- W4385986146 creator A5021137697 @default.
- W4385986146 creator A5031095771 @default.
- W4385986146 creator A5032105362 @default.
- W4385986146 creator A5032494504 @default.
- W4385986146 creator A5046465689 @default.
- W4385986146 creator A5049888805 @default.
- W4385986146 creator A5052976343 @default.
- W4385986146 creator A5069717830 @default.
- W4385986146 creator A5075774578 @default.
- W4385986146 creator A5079531770 @default.
- W4385986146 creator A5085309946 @default.
- W4385986146 date "2023-10-01" @default.
- W4385986146 modified "2023-10-18" @default.
- W4385986146 title "Type 1 Diabetes Impairs Endothelium-Dependent Relaxation Via Increasing Endothelial Cell Glycolysis Through Advanced Glycation End Products, PFKFB3, and Nox1-Mediated Mechanisms" @default.
- W4385986146 cites W1939173782 @default.
- W4385986146 cites W1966316309 @default.
- W4385986146 cites W1970271227 @default.
- W4385986146 cites W1983613841 @default.
- W4385986146 cites W1986877326 @default.
- W4385986146 cites W1990253071 @default.
- W4385986146 cites W2011850094 @default.
- W4385986146 cites W2013405562 @default.
- W4385986146 cites W2013524893 @default.
- W4385986146 cites W2026685522 @default.
- W4385986146 cites W2041899253 @default.
- W4385986146 cites W2070669901 @default.
- W4385986146 cites W2080294402 @default.
- W4385986146 cites W2104372526 @default.
- W4385986146 cites W2105817828 @default.
- W4385986146 cites W2110174113 @default.
- W4385986146 cites W2117559470 @default.
- W4385986146 cites W2127255821 @default.
- W4385986146 cites W2135145359 @default.
- W4385986146 cites W2146173783 @default.
- W4385986146 cites W2150405879 @default.
- W4385986146 cites W2171284332 @default.
- W4385986146 cites W2400106959 @default.
- W4385986146 cites W2520914124 @default.
- W4385986146 cites W2566273359 @default.
- W4385986146 cites W2601495974 @default.
- W4385986146 cites W2619678328 @default.
- W4385986146 cites W2734717774 @default.
- W4385986146 cites W2738386976 @default.
- W4385986146 cites W2768787879 @default.
- W4385986146 cites W2887373570 @default.
- W4385986146 cites W2892639011 @default.
- W4385986146 cites W2900814239 @default.
- W4385986146 cites W2901021262 @default.
- W4385986146 cites W2950902413 @default.
- W4385986146 cites W2963481938 @default.
- W4385986146 cites W2973932371 @default.
- W4385986146 cites W2982302501 @default.
- W4385986146 cites W3089179536 @default.
- W4385986146 cites W3104558320 @default.
- W4385986146 cites W3158347263 @default.
- W4385986146 cites W3162727892 @default.
- W4385986146 cites W3198889226 @default.
- W4385986146 cites W3203122580 @default.
- W4385986146 cites W4210696949 @default.
- W4385986146 cites W4281795226 @default.
- W4385986146 cites W4296162804 @default.
- W4385986146 doi "https://doi.org/10.1161/hypertensionaha.123.21341" @default.
- W4385986146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37729634" @default.
- W4385986146 hasPublicationYear "2023" @default.
- W4385986146 type Work @default.
- W4385986146 citedByCount "0" @default.
- W4385986146 crossrefType "journal-article" @default.
- W4385986146 hasAuthorship W4385986146A5015104391 @default.
- W4385986146 hasAuthorship W4385986146A5016702603 @default.
- W4385986146 hasAuthorship W4385986146A5016817055 @default.
- W4385986146 hasAuthorship W4385986146A5021137697 @default.
- W4385986146 hasAuthorship W4385986146A5031095771 @default.
- W4385986146 hasAuthorship W4385986146A5032105362 @default.
- W4385986146 hasAuthorship W4385986146A5032494504 @default.
- W4385986146 hasAuthorship W4385986146A5046465689 @default.
- W4385986146 hasAuthorship W4385986146A5049888805 @default.
- W4385986146 hasAuthorship W4385986146A5052976343 @default.
- W4385986146 hasAuthorship W4385986146A5069717830 @default.
- W4385986146 hasAuthorship W4385986146A5075774578 @default.
- W4385986146 hasAuthorship W4385986146A5079531770 @default.
- W4385986146 hasAuthorship W4385986146A5085309946 @default.
- W4385986146 hasConcept C126322002 @default.
- W4385986146 hasConcept C147990577 @default.
- W4385986146 hasConcept C170493617 @default.
- W4385986146 hasConcept C181199279 @default.
- W4385986146 hasConcept C185592680 @default.
- W4385986146 hasConcept C20251656 @default.
- W4385986146 hasConcept C2776061955 @default.
- W4385986146 hasConcept C2778592357 @default.
- W4385986146 hasConcept C2779719074 @default.
- W4385986146 hasConcept C48349386 @default.
- W4385986146 hasConcept C55493867 @default.
- W4385986146 hasConcept C55885012 @default.